Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions.

Asian equities ended the week mixed, led higher by Hong Kong, especially Hong Kong-listed growth stocks, while Taiwan underperformed.

Jeremy Fang, a sales officer at a Chinese aluminium products maker, is trying to export more to markets in Asia, Africa and ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

Johnson & Johnson executive praises China's biotech innovation in oncology and immunology, highlighting potential future ...